Connect with us

Media & Technology

SNPW (Sun Pacific Holding Corp) Power Brewing: 50MW solar farm project in Durango Mexico MOU with Atlas Medrecycler 48,000 SF New Partnership Queensland Australia Solar Farm.

Published

on

SNPW (Sun Pacific Holding Corp) a stock with a long history of explosive moves many of which we hace covered here at Microcap is starting to trend up on a suruge of volume and this one has a real gap to fill. SNPW has been busy updating shareholders; The proposed 50MW solar farm project in Durango Mexico continues its development after a delay due to Covid-19 and is currently undergoing a financial review with a selected EPC and funding group. This partnership is targeting a financial closing and the commencement of construction in 2021. The Company’s recently announced MOU with Atlas Transit Solutions to collaborate on the development of a high efficiency off grid digital plug and play modular unit will develop a new SMART Bus Shelter which integrates a new software as a service that enhances the commuters experience while driving a new unique and proprietary product offering.  

The Company’s subsidiary Medrecycler RI, Inc. continues to progress through the regulatory process for the approval to construct a 48,000 SF state-of-the-art pyrolysis facility expected to process 70 tons of medical waste per day. With approval and the completion of financing, the project should be operational by the end of 2021. The Company also just announced its subsidiary has entered into a partnership agreement to develop Queensland Australia Solar Farm. National Mechanical Group (“NMG”) and Renewable Energy Engineers Aust. (“REEA”) will develop an initial 100-megawatt solar farm in Queensland, Australia to help the energy grid in that area. SNPW has legions of shareholders, a long history of big moves, ready liquidity and its getting noticed here. 

SNPW (Sun Pacific Holding Corp) with executive offices out of Manalapan, New Jersey, operates a number of subsidiaries. The Company is pink current and a fully reporting and owns a valuable patent portfolio related to solar including patents on various innovations relating to improved photovoltaic (PV) solar power panel constructions, proprietary methods of manufacture, and production line systems to be used during the planned manufacture of solar power in high volume production environments. Sun Pacific is constantly expanding on its patent portfolio reporting last year it has filed three (3) additional applications for patent. 

SNPW has come a long way since February 5, 2020 when Microcapdaily first reported on the Company stating: “SNPW was the place to be in the last months of 2019 which saw the stock make a significant move from an $0.0003 start to highs over $0.007.” Sun Pacific is a green energy company specializing in solar and waste to energy technologies; the Company’s subsidiary just reported DEM has just issued a letter of intent to grant a license for Medrecycler’s cutting edge #renewableenergy process. Medrecycler has been building out its flagship Medical Waste to Energy facility in West Warwick, Rhode Island and has already Initiated multi-year contract discussions with several national haulers to receive up to 70 tons per day of plant feed stock. Medrecycler plans to convert regulated medical waste to renewable energy starting at around 35 tons of waste per day and moving up to 70 tons per day being transformed into renewable energy. The new 48,000 sq, ft facility is housed in a small portion of an existing well over a half-million square ft building within an industrial park. Medrecycler will create approximately 20-30 new jobs for local residents once operational and fully completed. SNPW has massive liquidity, legions of new shareholders and significant developments driving this powerhouse run.  

Sun Pacific operates a number of subsidiaries including Street Smart Outdoor, Sun Pacific Power and Medrecycler. Street Smart Outdoor is a rapidly growing street furniture outdoor advertising company offer advertising space on bus shelters and bus benches, smart solar digital shelters, and place-based solar trash bins in small towns on high trafficked main roads. The company currently maintains over 1000 signs in its outdoor advertising marketplace and has several new signs in new towns to roll out this year.  

Sun Pacific Power builds competitively priced “Next Generation” solar panels and lighting products made primarily in the USA. Sun Pacific Power has eight world-wide manufacturing and assembly locations including five in the United States. Sun Pacific Power bus shelters are providing green, renewable, solar-powered shelters that will have digital or static displays for advertising purposes and things like being able to post Silver and Amber alerts. With large screens to display advertisements and relevant information, such as public notifications and safety alerts. Sun Pacific Power is now offering solar powered LED trash bins.  

To Find out the inside Scoop on SNPW Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

SNPW

SNPW has been busy updating shareholders in 2021; in March the Company provided a positive outlook for 2021 driven by new partnerships and expected project launches that the Company believes should create a new foundation for growth. These include the following: 

The proposed 50MW solar farm project in Durango Mexico continues its development after a delay due to Covid-19 and is currently undergoing a financial review with a selected EPC and funding group. This partnership is targeting a financial closing and the commencement of construction in 2021.  

The Company’s membership with Geopath is expected to support a strategy for expanding our market reach to targeted advertisers in the OOH industry. By adding the Company’s subsidiary Street Smart Outdoor Corp’s inventory to the Geopath Insights Suite we should witness enhanced metrics that are key to advertisers both locally and nationwide that empowers an increase in data-driven buying.  

The Company’s recently announced MOU with Atlas Transit Solutions to collaborate on the development of a high efficiency off grid digital plug and play modular unit will develop a new SMART Bus Shelter which integrates a new software as a service that enhances the commuters experience while driving a new unique and proprietary product offering.  

The Company’s subsidiary Medrecycler RI, Inc. continues to progress through the regulatory process for the approval to construct a 48,000 SF state-of-the-art pyrolysis facility expected to process 70 tons of medical waste per day. With approval and the completion of financing, the project should be operational by the end of 2021.   

The Company’s subsidiary National Mechanical Group is taking steps towards the testing and preparation for UL certification for its patented glass-less solar panels for commercial and government use. The approval for this new proprietary product should provide the Company with licensing and partnership arrangements that should drive the monetization of this unique company held IP. 

On June 15, SNPW announced its wholly owned subsidiary, National Mechanical Group (“NMG”) has entered into a partnership agreement to develop Queensland Australia Solar Farm. National Mechanical Group (“NMG”) and Renewable Energy Engineers Aust. (“REEA”) will develop an initial 100-megawatt solar farm in Queensland, Australia to help the energy grid in that area. 

The partnership was formed to develop the solar farm opportunity by bringing together expertise in solar design and development with “in-country” expertise in building, construction, technology, and regulatory knowledge and skills. The team is actively engaged in sourcing components and capital with an end goal of developing up to 100-Megawatt solar farm. The team has currently received a lands rights agreement for 750 acres and one power purchase agreement for the solar farm and is in discussions with component manufacturers and investment partners. 

Nicholas Campanella, CEO of Sun Pacific Holding Corp, stated, “We are excited to work with the team at REEA in developing this opportunity and more in Australia. The initial discussions and development so far have been successful, and we look forward to developing this opportunity for all of our stakeholders.” 

For More on SNPW Subscribe Right Now!

SNPW (Sun Pacific Holding Corp) a stock with a long history of explosive moves many of which we hace covered here at Microcap is starting to trend up on a suruge of volume and this one has a real gap to fill. SNPW has been busy updating shareholders; The proposed 50MW solar farm project in Durango Mexico continues its development after a delay due to Covid-19 and is currently undergoing a financial review with a selected EPC and funding group. This partnership is targeting a financial closing and the commencement of construction in 2021. The Company’s recently announced MOU with Atlas Transit Solutions to collaborate on the development of a high efficiency off grid digital plug and play modular unit will develop a new SMART Bus Shelter which integrates a new software as a service that enhances the commuters experience while driving a new unique and proprietary product offering.   The Company’s subsidiary Medrecycler RI, Inc. continues to progress through the regulatory process for the approval to construct a 48,000 SF state-of-the-art pyrolysis facility expected to process 70 tons of medical waste per day. With approval and the completion of financing, the project should be operational by the end of 2021. The Company also just announced its subsidiary has entered into a partnership agreement to develop Queensland Australia Solar Farm. National Mechanical Group (“NMG”) and Renewable Energy Engineers Aust. (“REEA”) will develop an initial 100-megawatt solar farm in Queensland, Australia to help the energy grid in that area. SNPW has legions of shareholders, a long history of big moves, ready liquidity and its getting noticed here. We will be updating on SNPW when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with SNPW.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in SNPW either long or short and we have not been compensated for this article.

Continue Reading
3 Comments

3 Comments

  1. jay

    June 18, 2021 at 6:23 am

  2. jay

    June 18, 2021 at 10:12 am

    $SNPW are in the UL Certification Approval Process ongong for months now for There Solar Panels etc.Also there financials are fully reporting with SEC and consoldated finacials are audited.Also Has been discussed last summer by CEO on there twitter account they will be building a Solar Panel Manufactoring Factory in the USA. too

  3. jay

    August 10, 2021 at 11:31 am

    $SNPW #ALERT> There is no other pennystock that is trading around .02 on the planet that i am aware of Developing Constructing involved in $200m+ in Solar Farms. The Nasdaq,Nyse Solar Stocks are in mutiple $’s and much much higher then that do these projects.

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

LAVA Therapeutics (NASDAQ: LVTX) Gammabody™ Platform Gains Momentum

Published

on

LAVA Therapeutics N.V. (NASDAQ: LVTX) shares soared 106% as the company announced that Janssen Biotech, Inc. chose a lead candidate.

LAVA Therapeutics N.V. (NASDAQ: LVTX) shares soared 106% as the company announced that Janssen Biotech, Inc., a part of the Janssen Pharmaceutical Companies of Johnson & Johnson, chose a lead candidate aimed at an undisclosed tumor-associated antigen for further development towards clinical settings.

GAMMABODY™ PLATFORM

LAVA primarily focuses on revolutionizing cancer therapy by developing its Gammabody™ platform. This platform enables them to create bispecific gamma delta T cell engagers that can activate a specific subset of gamma-delta T cells called Vγ9Vδ2 (Vgamma9 Vdelta2) T cells. By utilizing this approach, they aim to enhance the natural recognition of tumors, guide Vγ9Vδ2 T cells to target the tumor cells directly and trigger a cascade of immune responses.

To Discover the Inside Scoop on LVTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

What sets their Gammabody™ drug candidates apart is their exceptional performance and safety profiles observed in preclinical studies. Compared to other bispecific T cell engager approaches, their candidates have demonstrated superior efficacy and preferred targeting tumor cells. This targeted approach has the potential to minimize toxicity in healthy tissues.

In May 2020, LAVA entered into a research collaboration and license agreement with Janssen, a subsidiary of the Janssen Pharmaceutical Companies of Johnson & Johnson. This collaboration aimed to discover and develop novel bispecific antibody-based gamma delta T cell engagers for cancer treatment. The agreement was facilitated by Johnson & Johnson Innovation, emphasizing their commitment to fostering innovation in the field.

As part of the collaboration, LAVA had the opportunity to receive potential milestone payments and royalties based on the successful development, regulatory approvals, and commercialization of the candidates. This incentivized LAVA to actively pursue the discovery and advancement of promising lead candidates. 

The collaboration represents a remarkable milestone many early-stage biotech companies aspire to achieve. Partnering with a program brings numerous benefits, including reduced risk of dilution through milestone payments as the trials advance and streamlined commercialization once the product receives approval.

Under the terms of the agreement, Janssen will assume responsibility for the selected candidate’s future clinical development, manufacturing, and commercialization. This includes bearing the costs and expenses associated with these activities.

Stephen Hurly, LAVA Therapeutics’s president and chief executive officer, expressed satisfaction with Janssen’s selection of a lead candidate for clinical studies. He emphasized LAVA’s pioneering role in developing gamma-delta bispecific antibodies through their proprietary Gammabody platform. This platform and LAVA’s extensive expertise in bispecific antibody development position them at the forefront of advancing novel therapies for cancer patients.

In summary, LAVA Therapeutics’ collaboration with Janssen has reached a significant milestone in selecting a lead candidate for further development toward clinical studies. This progress underscores LAVA’s dedication to leveraging its Gammabody platform and expertise in bispecific antibody development to revolutionize cancer treatment.

We will update you on LVTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Continue Reading

Featured

Onfolio Holdings (NASDAQ: ONFO) Unleashing the Power of AI

Published

on

Onfolio Holdings Inc (NASDAQ: ONFO), a technology services company, has recently introduced an advanced generative AI search function for its subsidiary, MightyDeals.com.

Onfolio Holdings Inc (NASDAQ: ONFO), a technology services company, has recently introduced an advanced generative AI search function for its subsidiary, MightyDeals.com. The implementation of this innovative AI tool, powered by chatGPT-style Large Language Models (LLMs), has resulted in a surge of 105% in the company’s stock price and sparked tons of investor interest. The company has a 3.28M float and, at the time of writing, has traded 20x that amount, with a colossal 60M shares exchanging hands.

Revolutionizing User Experience and Driving Stock Surge

With the integration of AI search on MightyDeals.com, customers can now use natural language to describe the products they seek, simplifying the buying process. The AI tool utilizes contextual understanding and description analysis of hundreds of active deals to generate instant search results based on users’ queries. By enhancing the user experience, Onfolio Holdings anticipates increased user return rates, higher site interaction rates, and elevated revenues for MightyDeals.com. This groundbreaking development has attracted positive attention, significantly increasing Onfolio Holdings’ stock price.

To Discover the Inside Scoop on ONFO, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Evaluating Financial Performance

While the stock surge indicates investor enthusiasm, assessing Onfolio Holdings’ financial performance is crucial for comprehensive investment analysis. The positive earnings growth of +44.44% and revenue growth of +22.74% contribute to the company’s optimistic outlook. However, investors should be cautious of the negative net profit margin of -190.75% and the lack of available price/book ratio data. Monitoring the company’s financial performance leading up to the next reporting date on August 30, 2023, is advised to understand its profitability and overall stability better.

Investment Outlook and Future Prospects

Considering the stock surge and optimistic price forecasts, Onfolio Holdings has promising prospects. Analysts offer a median target price of $3.00 for the company’s stock, signaling an expectation of significant growth within the next 12 months. However, it is essential to note that Onfolio Holdings operates at a loss. Investors should thoroughly evaluate the company’s long-term growth potential and weigh the potential returns against the inherent risks before making investment decisions.

About MightyDeals.com

Mighty Deals is a free daily deals website aimed at creative professionals focusing on products and services for web designers and developers. The site offers fantastic deals on quality fonts, templates, apps, add-ons, plug-ins, ebooks, icons, and more. The site provides discounts on packages which usually range between 50%-97% off but are only available for a limited time. MightyDeals.com boasts an exceptional return rate from its users and is one of Onfolio Holdings’ highest revenue-generating subsidiaries.

About Onfolio Holdings Inc.

Onfolio acquires and manages a diversified portfolio of online businesses across a broad range of verticals, each with a niche content focus and brand identity. Onfolio acquires firms that meet its investment criteria, being that such businesses operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by our existing team or have strong management teams largely in place. The Company excels at finding acquisition opportunities where the seller has not fully optimized their business. Onfolio’s experience and skillset allow it to add increased value to these existing businesses.

Conclusion

Onfolio Holdings’ introduction of the generative AI search function for MightyDeals.com has increased the company’s stock price, reflecting the market’s positive response to this innovative technology. The enhanced user experience and the potential for increased revenues have positioned Onfolio Holdings as a leader in the tech industry. However, investors must carefully consider the company’s financial performance and evaluate its long-term growth potential before making investment decisions. Monitoring the company’s performance to the next reporting date will provide valuable insights into its financial health and stability.

We will update you on ONFO when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by James from Pixabay

Continue Reading

Featured

Enveric Biosciences (NASDAQ: ENVB) Pioneering the Future of Anxiety Disorder Treatment

Published

on

Enveric Biosciences, Inc. (NASDAQ: ENVB) shares surged 78% this morning upon approval of some fantastic news.

Enveric Biosciences, Inc. (NASDAQ: ENVB) shares surged 78% this morning upon approval of some fantastic news. The United States Patent and Trademark Office has granted them a notice of allowance for their patent application concerning a groundbreaking chemical compound called EB-373. This compound is being developed to address the treatment of anxiety disorders.

The forthcoming patent, titled “C4-Carbonothioate-Substituted Tryptamine Derivatives and Methods of Using,” encompasses claims for the composition of matter of a family of revolutionary prodrug derivatives of psilocin. Enveric’s lead product candidate, EB-373, stands out among these derivatives. A Notice of Allowance signifies that the USPTO has determined that a patent should be granted based on the submitted application.

To Discover the Inside Scoop on ENVB, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Enveric’s commitment to innovation extends beyond EB-373. They have also submitted additional patent applications to the USPTO, exploring psilocin prodrugs with unique crystalline molecular structures. Moreover, they have taken proactive steps to pursue global coverage of the EVM201 and EVM301 Series through companion Patent Cooperation Treaty and non-US national patent applications. Encouragingly, positive International Search Reports and written opinions have been received under the Patent Cooperation Treaty for most of these applications.

Joseph Tucker, Ph.D., Enveric’s director and CEO, underlined the significance of the USPTO’s favorable decision concerning their lead candidate, EB-373. He highlighted the innovative designs of their psilocin prodrugs within the EVM201 series, differentiating them from conventional counterparts like psilocybin. These novel designs hold the potential to deliver more rapid therapeutic effects, precise control, and reduced gastrointestinal side effects. Tucker emphasized that securing a robust intellectual property portfolio for their new chemical entity prodrugs is pivotal to Enveric’s value proposition and integral to their business strategy of developing cutting-edge small-molecule therapeutics to address mental health disorders.

We will update you on ENVB when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gino Crescoli from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.